Degron Therapeutics logo
Healthcare & Life Sciences

Degron Therapeutics

Degron Therapeutics is a series a startup based in China. 1 investor tracked.

Activeseries-a
series-a
Stage
2020
Founded
1
Investors

About Degron Therapeutics

Based in China, Degron Therapeutics is a startup founded in 2020. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

A biotechnology company developing novel medicines using its proprietary GlueXplorer drug discovery platform for molecular glue degraders.

Explore Degron Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in China